Conversion from calcineurin-inhibitor (CNI) based immunosuppression to Sirolimus in chronic CNI toxicity after renal transplantation

被引：0
|
作者：
Diekmann, F [1 ]
Waiser, J [1 ]
Einecke, G [1 ]
Dragun, D [1 ]
Fritsche, L [1 ]
Neumayer, HH [1 ]
Budde, K [1 ]
机构：
[1] Charite, Berlin, Germany
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：364A / 364A
页数：1
相关论文
共 50 条
  • [41] Benefit of early conversion from CNI-based to everolimus-based immunosuppression in heart transplantation
    Gude, Einar
    Gullestad, Lars
    Arora, Satish
    Simonsen, Svein
    Hoel, Ina
    Hartmann, Anders
    Holdaas, Hallvard
    Fiane, Arnt E.
    Geiran, Odd R.
    Andreassen, Arne K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2010, 29 (06): : 641 - 647
  • [42] Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations
    Arns, W.
    Budde, K.
    Eitner, F.
    Gwinner, W.
    Hugo, C.
    Pressmar, K.
    Weimann, A.
    Witzke, O.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2011, 136 (49) : 2554 - 2559
  • [43] SRL-based immunosuppression vs. CNI minimization in pediatric renal transplant recipients with chronic CNI nephrotoxicity
    Hoecker, Britta
    Feneberg, Reinhard
    Koepf, Sabine
    Weber, Lutz T.
    Waldherr, Ruediger
    Wuehl, Elke
    Toenshoff, Burkhard
    PEDIATRIC TRANSPLANTATION, 2006, 10 (05) : 593 - 601
  • [44] Evolution of chronic renal dysfunction after conversion from calcineurin inhibitors (CNI) to mycophenolate mofetil monotherapy in liver transplant recipients
    Manrique, Alejandro
    Jimenez, Carlos
    Ortega, Patricia
    Abradelo, Manuel
    Meneu, Juan C.
    Gimeno, Alberto
    Perez, Baltasar
    Calvo, Jorge
    Donat, Maria
    Cambra, Felix
    Lopez, Rose M.
    Morales, Jose M.
    Moreno, Enrique
    TRANSPLANT INTERNATIONAL, 2007, 20 : 32 - 32
  • [45] Mechanisms of improvement in renal function after conversion to sirolimus (SRL) from a calcineurin-inhibitor (CI) regimen in patients with chronic transplant nephropathy (CTN).
    Barakat, IB
    Zayas, CF
    Guasch, A
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 365A - 365A
  • [46] Renal Allograft Outcome in Combined Liver-Kidney Transplant (CLKT) on Calcineurin Inhibitor (CNI) vs. CNI and Mycophenolate (M) Maintenance Immunosuppression.
    Campara, Maya
    Jeon, Hoonbae
    Tzvetanov, Ivo
    Oberholzer, Jose
    Benedetti, Enrico
    Tang, Ignatius
    AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 533 - 534
  • [47] Calcineurin-Inhibitor Free Sirolimus-Based Immunosuppression in Pediatric Heart Transplant Recipients
    Rossano, Joseph W.
    Ryan, Rachel M.
    Orfanelli, Laura
    McCandless, Karen V.
    Kaufman, Beth D.
    Lin, Kimberly Y.
    Paridon, Stephen M.
    Hanna, Brian D.
    Shaddy, Robert E.
    CIRCULATION, 2012, 126 (21)
  • [48] 3 Year results of a prospective case control study using reduced dose calcineurin inhibitor (CNI) with sirolimus (SRL) compared to full dose CNI with mycophenylate mofetil (MMF) for immunosuppression in kidney transplantation.
    Formica, RN
    Kulkarni, SL
    Friedman, AL
    Bia, MJ
    Lorber, MI
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 : 241 - 241
  • [49] IMPROVEMENT IN GLUCOSE REGULATION AND VASCULAR FUNCTION IN RENAL TRANSPLANT RECIPIENTS CONVERTED FROM CALCINEURIN-INHIBITOR TO SIROLIMUS-BASED IMMUNOSUPPRESSION
    Messineo, A.
    Viecelli, A.
    Chan, D.
    Dogra, G.
    Lim, W.
    NEPHROLOGY, 2010, 15 : 60 - 61
  • [50] Hyaline sclerosis of the renal vasa recta in chronic calcineurin-inhibitor toxicity
    Ngae, MY
    Loutzenhiser, R
    Benediktsson, H
    LABORATORY INVESTIGATION, 2005, 85 : 269A - 269A
12345